Abigail C. Killen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abigail C. Killen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jana Koth
MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK
2 shared publications - Mathilda T. M. Mommersteeg
University of Oxford
2 shared publications Andrew Jefferson
Micron Advanced Bioimaging Unit, Department of Biochemistry, South Parks Road, Oxford OX1 3QU, UK
1 shared publicationBerthold Göttgens
Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge 3 Department of Haematology Cambridge CB2 0AW , UK
1 shared publicationEsra Sengul
University of Oxford
1 shared publication- Florian Bonkhofer
Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford 2 MRC Molecular Haematology Unit Oxford OX3 9DS , UK
1 shared publication
Latest Publications
- Open Access
Injured endocardium obtains characteristics of haemogenic endothelium during adult zebrafish heart regeneration
Summary: Reactivation of embryonic developmental pathways during regeneration aims to restore tissue architecture and functionality. We previously reported that following cryoinjury, a heterogeneous population of Runx1-expressing endocardial cells differentially upregulates genes associate with scarring and myofibroblast identity. Further analysis of our published RNAseq data alongside 5 publicly available datasets now identifies additional heterogeneity in the Runx1-positive injured endocardium. Here, we show that the endocardium also reactivates a dormant endocardial-to-haematopoietic transition (EHT) mechanism. Runx1-expressing endocardial cells upregulate genes associated with haemogenesis and morphologically display features of EHT. Live imaging shows cells budding off the endocardium and lineage analysis identifies overlap with leukocyte markers. Ablation of runx1 function further shifts differentiation of the endocardium towards the EHT fate. The identification of transient runx1 -expressing cells transitioning towards myofibroblast or haemogenic endocardium identities demonstrates the complexity of the zebrafish endocardial injury response and highlights the role of Runx1 in regulating cell fate decisions in the endocardium.
Open AccessInjured endocardium obtains characteristics of haemogenic endothelium during adult zebrafish heart regeneration
Summary: Reactivation of embryonic developmental pathways during regeneration aims to restore tissue architecture and functionality. We previously reported that following cryoinjury, a heterogeneous population of Runx1-expressing endocardial cells differentially upregulates genes associate with scarring and myofibroblast identity. Further analysis of our published RNAseq data alongside 5 publicly available datasets now identifies additional heterogeneity in the Runx1-positive injured endocardium. Here, we show that the endocardium also reactivates a dormant endocardial-to-haematopoietic transition (EHT) mechanism. Runx1-expressing endocardial cells upregulate genes associated with haemogenesis and morphologically display features of EHT. Live imaging shows cells budding off the endocardium and lineage analysis identifies overlap with leukocyte markers. Ablation of runx1 function further shifts differentiation of the endocardium towards the EHT fate. The identification of transient runx1 -expressing cells transitioning towards myofibroblast or haemogenic endocardium identities demonstrates the complexity of the zebrafish endocardial injury response and highlights the role of Runx1 in regulating cell fate decisions in the endocardium.
- Open Access
- 15 April 2020
- Published by The Company of Biologists in Development
- Vol. 147 (8)
Runx1 promotes scar deposition and inhibits myocardial proliferation and survival during zebrafish heart regeneration
Runx1 is a transcription factor that plays a key role in determining the proliferative and differential state of multiple cell types, during both development and adulthood. Here, we report how Runx1 is specifically upregulated at the injury site during zebrafish heart regeneration, and that absence of runx1 results in increased myocardial survival and proliferation, and overall heart regeneration, accompanied by decreased fibrosis. Using single cell sequencing, we found that the wild-type injury site consists of Runx1-positive endocardial cells and thrombocytes that induce expression of smooth muscle and collagen genes. Both these populations cannot be identified in runx1 mutant wounds that contain less collagen and fibrin. The reduction in fibrin in the mutant is further explained by reduced myofibroblast formation and upregulation of components of the fibrin degradation pathway, including plasminogen receptor annexin 2A as well as downregulation of plasminogen activator inhibitor serpine1 in myocardium and endocardium, resulting in increased levels of plasminogen. Our findings suggest that Runx1 controls the regenerative response of multiple cardiac cell types and that targeting Runx1 is a novel therapeutic strategy for inducing endogenous heart repair.
- 15 April 2020
- Published by The Company of Biologists in Development
- Vol. 147 (8)
Open AccessRunx1 promotes scar deposition and inhibits myocardial proliferation and survival during zebrafish heart regeneration
Runx1 is a transcription factor that plays a key role in determining the proliferative and differential state of multiple cell types, during both development and adulthood. Here, we report how Runx1 is specifically upregulated at the injury site during zebrafish heart regeneration, and that absence of runx1 results in increased myocardial survival and proliferation, and overall heart regeneration, accompanied by decreased fibrosis. Using single cell sequencing, we found that the wild-type injury site consists of Runx1-positive endocardial cells and thrombocytes that induce expression of smooth muscle and collagen genes. Both these populations cannot be identified in runx1 mutant wounds that contain less collagen and fibrin. The reduction in fibrin in the mutant is further explained by reduced myofibroblast formation and upregulation of components of the fibrin degradation pathway, including plasminogen receptor annexin 2A as well as downregulation of plasminogen activator inhibitor serpine1 in myocardium and endocardium, resulting in increased levels of plasminogen. Our findings suggest that Runx1 controls the regenerative response of multiple cardiac cell types and that targeting Runx1 is a novel therapeutic strategy for inducing endogenous heart repair.